Finance

Lists
2196:HKG
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
HK$ 17.36
+1.22%
(+0.21) 1D
10-р сарын 16, 10:20:59 (GMT+8)  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2196...
Open
HK$ 17.32
High
HK$ 17.55
Low
HK$ 17.23
Mkt. cap
67.09 тэрбум
Avg. vol.
3.62 сая
Volume
944.50 мян
Dividend
2.59%
Quarterly dividend
HK$ 0.11
Ex-dividend date
2026 оны 7-р сарын 27
P/E ratio
11.50
52-wk high
HK$ 24.84
52-wk low
HK$ 14.90
EPS
HK$ 1.51
Shares outstanding
551.94 сая
No. of employees
41 мян
Open
HK$ 17.32
High
HK$ 17.55
Low
HK$ 17.23
Mkt. cap
67.09 тэрбум
Avg. vol.
3.62 сая
Volume
944.50 мян
Dividend
2.59%
Quarterly dividend
HK$ 0.11
Ex-dividend date
2026 оны 7-р сарын 27
P/E ratio
11.50
52-wk high
HK$ 24.84
52-wk low
HK$ 14.90
EPS
HK$ 1.51
Shares outstanding
551.94 сая
No. of employees
41 мян
News stories
From web sources and news partners
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOLiu Yi | Wen Deyong
Employees40.7 мян
Founded1994
Headquarters-
SectorPharmaceutical industry
Last report
2026 оны 8-р сарын 25
Fiscal period
Q2 2026
- / -
Revenue / Est. (CNY)
10.37 тэрбум / 10.66 тэрбум
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
9.88 тэрбум
12.27 тэрбум
10.07 тэрбум
10.37 тэрбум
Cost of goods sold
5.08 тэрбум
5.65 тэрбум
5.07 тэрбум
5.23 тэрбум
Cost of revenue
5.08 тэрбум
5.65 тэрбум
5.07 тэрбум
5.23 тэрбум
Research and development expenses
1.01 тэрбум
1.28 тэрбум
896.79 сая
1.19 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.10 тэрбум
4.44 тэрбум
3.27 тэрбум
3.35 тэрбум
Operating expense
4.04 тэрбум
5.92 тэрбум
4.19 тэрбум
4.63 тэрбум
Total operating expenses
9.12 тэрбум
11.57 тэрбум
9.26 тэрбум
9.86 тэрбум
Operating income
758.38 сая
699.05 сая
813.78 сая
505.27 сая
Other non operating income
-116.85 сая
107.33 сая
2.03 сая
-13.28 сая
EBT including unusual items
1.12 тэрбум
1.27 тэрбум
1.36 тэрбум
1.23 тэрбум
EBT excluding unusual items
1.49 тэрбум
1.10 тэрбум
1.21 тэрбум
1.07 тэрбум
Income tax expense
162.98 сая
82.80 сая
277.92 сая
159.73 сая
Effective tax rate
14.57%
6.50%
20.47%
13.00%
Other operating expenses
-92.19 сая
117.57 сая
19.04 сая
74.01 сая
Net income
821.33 сая
847.27 сая
870.83 сая
850.64 сая
Net profit margin
8.31%
6.91%
8.64%
8.20%
Earnings per share
-
-
-
-
Interest and investment income
1.05 тэрбум
732.13 сая
689.67 сая
938.86 сая
Interest expense
-321.25 сая
-291.32 сая
-296.51 сая
-310.88 сая
Net interest expenses
727.28 сая
440.80 сая
393.16 сая
627.98 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
1.39 тэрбум
1.47 тэрбум
1.59 тэрбум
1.24 тэрбум
Gain or loss from assets sale
2.12 сая
-69.35 сая
-
-195.23 мян
AI content may include mistakes. Learn more
Google аппс